Mert Aktar

Insider Reports History

Entity
Individual
Location
C/O Paul Hastings Llp, 200 Park Avenue, New York, NY
Signature
By: /s/ Samantha Eldredge, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mert Aktar:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kyverna Therapeutics, Inc. Director Stock Option (right to buy) 87.7K Oct 21, 2024 Direct

Insider Reports Filed by Mert Aktar

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KYTX Kyverna Therapeutics, Inc. Oct 21, 2024 1 $0 4 Oct 24, 2024 Director
KYTX Kyverna Therapeutics, Inc. Oct 21, 2024 0 $0 3 Oct 24, 2024 Director